519 related articles for article (PubMed ID: 8989373)
21. Response of a radioresistant human melanoma cell line along the proton spread-out Bragg peak.
Petrović I; Ristić-Fira A; Todorović D; Korićanac L; Valastro L; Cirrone P; Cuttone G
Int J Radiat Biol; 2010 Sep; 86(9):742-51. PubMed ID: 20597839
[TBL] [Abstract][Full Text] [Related]
22. The radiosensitivity of total and quiescent cell populations in solid tumors to 290 MeV/u carbon ion beam irradiation in vivo.
Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Ono K
Acta Oncol; 2008; 47(6):1087-93. PubMed ID: 18607878
[TBL] [Abstract][Full Text] [Related]
23. Spectra of linear energy transfer and other dosimetry characteristics as measured in C290 MeV/n MONO and SOBP ion beams at HIMAC-BIO (NIRS, Japan) with different detectors.
Spurný F; Pachnerová Brabcová K; Ploc O; Ambrožová I; Mrázová Z
Radiat Prot Dosimetry; 2011 Feb; 143(2-4):519-22. PubMed ID: 21245064
[TBL] [Abstract][Full Text] [Related]
24. Failla Memorial lecture. The future of heavy-ion science in biology and medicine.
Tobias CA
Radiat Res; 1985 Jul; 103(1):1-33. PubMed ID: 3906741
[TBL] [Abstract][Full Text] [Related]
25. Determination of average LET of therapeutic proton beams using Al2O3:C optically stimulated luminescence (OSL) detectors.
Sawakuchi GO; Sahoo N; Gasparian PB; Rodriguez MG; Archambault L; Titt U; Yukihara EG
Phys Med Biol; 2010 Sep; 55(17):4963-76. PubMed ID: 20693613
[TBL] [Abstract][Full Text] [Related]
26. Heavy-ion effects on mammalian cells: inactivation measurements with different cell lines.
Wulf H; Kraft-Weyrather W; Miltenburger HG; Blakely EA; Tobias CA; Kraft G
Radiat Res Suppl; 1985; 8():S122-34. PubMed ID: 3867078
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of helium beam-modulator design to uncertainties in biological data.
Petti PL; Lyman JT; Castro JR
Med Phys; 1991; 18(3):506-12. PubMed ID: 1908045
[TBL] [Abstract][Full Text] [Related]
28. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C
Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508
[TBL] [Abstract][Full Text] [Related]
29. Biophysical calculation of cell survival probabilities using amorphous track structure models for heavy-ion irradiation.
Kase Y; Kanai T; Matsufuji N; Furusawa Y; Elsässer T; Scholz M
Phys Med Biol; 2008 Jan; 53(1):37-59. PubMed ID: 18182686
[TBL] [Abstract][Full Text] [Related]
30. High relative biologic effectiveness of carbon ion radiation on induction of rat mammary carcinoma and its lack of H-ras and Tp53 mutations.
Imaoka T; Nishimura M; Kakinuma S; Hatano Y; Ohmachi Y; Yoshinaga S; Kawano A; Maekawa A; Shimada Y
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):194-203. PubMed ID: 17707273
[TBL] [Abstract][Full Text] [Related]
31. Cell inactivation by beryllium, boron and carbon ions at the low-energy irradiation facility of the Naples University.
Scampoli P; Casale M; Durante M; Grossi G; Pugliese M; Gialanella G
Phys Med; 2001; 17 Suppl 1():141-2. PubMed ID: 11771539
[TBL] [Abstract][Full Text] [Related]
32. Improvement of spread-out Bragg peak flatness for a carbon-ion beam by the use of a ridge filter with a ripple filter.
Hara Y; Takada Y; Hotta K; Tansho R; Nihei T; Suzuki Y; Nagafuchi K; Kawai R; Tanabe M; Mizutani S; Himukai T; Matsufuji N
Phys Med Biol; 2012 Mar; 57(6):1717-31. PubMed ID: 22398392
[TBL] [Abstract][Full Text] [Related]
33. Cell biological basis for combination radiotherapy using heavy-ion beams and high-energy X-rays.
Demizu Y; Kagawa K; Ejima Y; Nishimura H; Sasaki R; Soejima T; Yanou T; Shimizu M; Furusawa Y; Hishikawa Y; Sugimura K
Radiother Oncol; 2004 May; 71(2):207-11. PubMed ID: 15110455
[TBL] [Abstract][Full Text] [Related]
34. Antiproton radiotherapy.
Bassler N; Alsner J; Beyer G; DeMarco JJ; Doser M; Hajdukovic D; Hartley O; Iwamoto KS; Jäkel O; Knudsen HV; Kovacevic S; Møller SP; Overgaard J; Petersen JB; Solberg TD; Sørensen BS; Vranjes S; Wouters BG; Holzscheiter MH
Radiother Oncol; 2008 Jan; 86(1):14-9. PubMed ID: 18158194
[TBL] [Abstract][Full Text] [Related]
35. Judgement on "hit or non-hit" of CHO cells exposed to accelerated heavy-ions (Fe- or Ar-ions) using division delay and CR-39 plastics as an indicator.
Mehnati P; Yatagai F; Tsuzuki T; Hanaoka F; Sasaki H
Fukuoka Igaku Zasshi; 2001 Mar; 92(3):46-57. PubMed ID: 11357328
[TBL] [Abstract][Full Text] [Related]
36. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay.
Calugaru V; Nauraye C; Noël G; Giocanti N; Favaudon V; Mégnin-Chanet F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1136-43. PubMed ID: 21075549
[TBL] [Abstract][Full Text] [Related]
37. Response of colony-forming units-spleen to heavy charged particles.
Ainsworth EJ; Kelly LS; Mahlmann LJ; Schooley JC; Thomas RH; Howard J; Alpen EL
Radiat Res; 1983 Oct; 96(1):180-97. PubMed ID: 6622650
[TBL] [Abstract][Full Text] [Related]
38. Radiobiological intercomparison of the 160 MeV and 230 MeV proton therapy beams at the Harvard Cyclotron Laboratory and at Massachusetts General Hospital.
Wouters BG; Skarsgard LD; Gerweck LE; Carabe-Fernandez A; Wong M; Durand RE; Nielson D; Bussiere MR; Wagner M; Biggs P; Paganetti H; Suit HD
Radiat Res; 2015 Feb; 183(2):174-87. PubMed ID: 25587741
[TBL] [Abstract][Full Text] [Related]
39. A nanodosimetry-based linear-quadratic model of cell survival for mixed-LET radiations.
Chris Wang CK; Zhang X
Phys Med Biol; 2006 Dec; 51(23):6087-98. PubMed ID: 17110772
[TBL] [Abstract][Full Text] [Related]
40. Experimental validation of the new nanodosimetry-based cell survival model for mixed neutron and gamma-ray irradiation.
Wang CK; Zhang X; Gifford I; Burgett E; Adams V; Al-Sheikhly M
Phys Med Biol; 2007 Sep; 52(17):N367-74. PubMed ID: 17762072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
